BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36372577)

  • 1. Sentinel lymph node biopsy in women over 70: Evaluation of rates of axillary staging and impact on adjuvant therapy in elderly women.
    Di Lena É; Antoun A; Hopkins B; Barone N; Do U; Meterissian S
    Surgery; 2023 Mar; 173(3):603-611. PubMed ID: 36372577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital.
    Heidinger M; Maggi N; Dutilh G; Mueller M; Eller RS; Loesch JM; Schwab FD; Kurzeder C; Weber WP
    World J Surg Oncol; 2023 Jun; 21(1):176. PubMed ID: 37287038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
    Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
    Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
    Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
    Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
    Thompson J; Le J; Hop A; Melnik M; Paulson J; Wright GP
    Ann Surg Oncol; 2021 Oct; 28(10):5716-5722. PubMed ID: 34333704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
    Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer.
    Aubry S; Strassle PD; Maduekwe U; Downs-Canner S
    J Surg Res; 2020 Dec; 256():13-22. PubMed ID: 32679224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
    Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
    Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer.
    Tejera D; Rana M; Basik M; Boileau JF; Margolese R; Prakash I; Meguerditchian AN; Muanza T; Monette J; Wong SM
    Breast Cancer Res Treat; 2021 Dec; 190(3):491-501. PubMed ID: 34542772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy.
    Tonneson JE; Hoskin TL; Durgan DM; Corbin KS; Goetz MP; Boughey JC
    Ann Surg Oncol; 2021 Dec; 28(13):8766-8774. PubMed ID: 34258721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
    Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
    J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
    FitzSullivan E; Bassett RL; Kuerer HM; Mittendorf EA; Yi M; Hunt KK; Babiera GV; Caudle AS; Black DM; Bedrosian I; Reyna C; Teshome M; Meric-Bernstam F; Hwang R
    Ann Surg Oncol; 2017 Mar; 24(3):652-659. PubMed ID: 27822630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
    Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
    Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
    Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.